OncoTalks | Oncology Insights at Your Fingertips

OncoTalks is the podcast for community oncology providers and clinicians who want to stay on top of new treatments and the latest advancements in oncology. Join Ontada Learn and community oncologists from The US Oncology Network as they explore oncology with a focus on the latest breakthroughs in cancer care. Expect concise, impactful discussions with practical clinical insights tailored for the real-world community oncology setting. Additionally, don’t miss OncoTalks Case Journeys , where experts deep dive into oncology patient cases and treatment journeys. Join as they conduct comprehensive case reviews, explore key learnings, and discuss the latest research and advances related to each case. Tune into OncoTalks and start unlocking pathways to better patient care today!

OncoTalks | Oncology Insights at Your Fingertips is a education podcast hosted by Ontada Learn, with 34 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Ontada Learn hosts OncoTalks | Oncology Insights at Your Fingertips, a education show with 34 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #41

  Micro-Series | Part 2 | Frontline Treatment Optimization in High-Risk and Transplant-Ineligible Multiple Myeloma

  Aug 14, 20264 min

  Dr. Edward Pearson reviews pivotal clinical trial data supporting anti-CD38-based regimens and explores how clinicians can balance efficacy, tolerability, and quality of life when managing high-risk and transplant-ineligible multiple myeloma. This episode is part of the micro-series, Optimizing Care in Multiple Myeloma: Perspectives on Treatment and Delivery Innovation. Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.

  ListenShow Notes
• 

  Episode #40

  Micro-Series | Part 1 | Navigating Care for Transplant-Ineligible Multiple Myeloma Patients

  Aug 14, 20264 min

  Dr. Edward Pearson discusses the growing role of anti-CD38-based quadruplet therapy and key considerations influencing frontline therapy selection for patients with newly diagnosed, transplant-ineligible multiple myeloma. This episode is part of the micro-series, Optimizing Care in Multiple Myeloma: Perspectives on Treatment and Delivery Innovation. Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.

  ListenShow Notes
• 

  Episode #44

  HER2 Testing in Solid Tumors

  Aug 5, 20261 min

  This learning module provides a brief overview of HER2 testing in metastatic non-small cell lung, bladder, rectal, cervical, biliary tract, ovarian, pancreatic, endometrial, and colon cancers, highlighting disease-specific testing approaches, interpretation of HER2 results, and key dosing and safety monitoring considerations. Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.

  ListenShow Notes
• 

  Episode #39

  Provider Perspectives on BTKi Selection in CLL

  Jul 22, 202612 min

  In this episode of OncoTalks, Dr. Yair Levy shares his approach to BTKi selection for patients with chronic lymphocytic leukemia (CLL), highlighting the growing role of second-generation BTK inhibitors, and the importance of tailoring treatment to individual patient characteristics. The discussion also explores the challenges providers face when navigating insurance requirements, medication access, and long-term adherence. Learn how thoughtful treatment selection and patient-centered education can help improve outcomes throughout the CLL treatment journey. Listen to Navigating the CLL Treatment Landscape: The Role of Physician Choice as Dr. Levy discusses why preserving physician autonomy is essential to delivering optimal, patient-centered oncology care. Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.

  ListenShow Notes
• 

  Episode #38

  Navigating the CLL Treatment Landscape: The Role of Physician Choice

  Jul 13, 20268 min

  In this episode of OncoTalks, host Tulsi Patel is joined by Dr. Yair Levy to discuss the growing impact of utilization management policies on chronic lymphocytic leukemia (CLL) care. As treatment options expand, personalized therapy selection is more critical than ever, yet step therapy requirements and payer restrictions are increasingly shaping clinical decisions. Dr. Levy shares real-world insights on how these policies affect patient outcomes, treatment adherence, and provider workload. Tune in to explore why preserving physician autonomy is essential to delivering optimal, patient-centered oncology care. Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.

  ListenShow Notes

Recent guests on OncoTalks | Oncology Insights at Your Fingertips. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.